Drug recall · March 10, 2021
Metoclopramide Injection USP recall
Why: Chemical contamination; Unknown brown residue adhering to the inside of one vial.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)
- Lots / codes
Lot # 31325335B, exp. date 07/2021
- Quantity
- 9,452 cartons
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Nationwide, including Puerto Rico
- Initiated
- February 15, 2021 · Voluntary: Firm initiated
- Classified
- March 3, 2021
- Reported
- March 10, 2021
- Ended
- August 26, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoclopramide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.